The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated
Nasdaq: LGND
Change
symbol:
     
 PROFILE
Ligand Pharmaceuticals is receptive to new ideas. The company develops small-molecule drugs that interact with hormone-activated intracellular receptors. Four of its products have received regulatory approval in the US or Europe: Panretin (AIDS-related Kaposi's sarcoma) and ONTAK (T-cell lymphoma) and Targretin (gel and oral formulations to treat skin lesions related to T-cell lymphoma). Its drug pipeline includes candidates targeting breast, renal, lung, and other cancers, as well as psoriasis, eczema, and acne. The firm also makes money from royalties and research alliances with such companies as Elan (which owns more than 20% of Ligand), Eli Lilly, Abbott Laboratories, and Pfizer.

 COMPETITION
Agouron Pharmaceuticals, Inc. (dossier)
Gilead Sciences, Inc. (GILD)
IDEC Pharmaceuticals Corporation (IDPH)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 48.10
1-Yr. Sales Growth: 17.6%
Employees: 356
Revenue per employee: $135,112.36

 KEY PEOPLE
• David E. Robinson
    CEO
• Paul V. Maier
    CFO

 CONTACT INFO
10275 Science Center Dr.
San Diego, CA 92121
US
Phone: 858-550-7500
Fax: 858-550-7506
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001